PortfoliosLab logoPortfoliosLab logo
AMAT vs. VRTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AMAT vs. VRTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Applied Materials, Inc. (AMAT) and Vertex Pharmaceuticals Incorporated (VRTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AMAT achieves a 121.28% return, which is significantly higher than VRTX's -1.86% return. Over the past 10 years, AMAT has outperformed VRTX with an annualized return of 38.86%, while VRTX has yielded a comparatively lower 17.15% annualized return.


AMAT

1D
2.64%
1M
28.92%
YTD
121.28%
6M
119.38%
1Y
234.96%
3Y*
60.05%
5Y*
34.02%
10Y*
38.86%

VRTX

1D
-0.03%
1M
-1.22%
YTD
-1.86%
6M
-1.57%
1Y
-2.31%
3Y*
9.16%
5Y*
18.18%
10Y*
17.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AMAT vs. VRTX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AMAT
Applied Materials, Inc.
121.28%59.60%1.13%67.97%-37.54%83.64%43.29%89.86%-34.92%59.86%
VRTX
Vertex Pharmaceuticals Incorporated
-1.86%12.58%-1.03%40.90%31.50%-7.08%7.94%32.13%10.58%103.42%

Correlation

The correlation between AMAT and VRTX is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.10

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Jul 24, 1991

0.26

The correlation between AMAT and VRTX shifts across timeframes, from 0.10 (1 year) to 0.26 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AMAT:

$453.23B

VRTX:

$114.03B

EPS

AMAT:

$10.61

VRTX:

$16.87

PE Ratio

AMAT:

53.45

VRTX:

26.38

PEG Ratio

AMAT:

6.80

VRTX:

2.19

PS Ratio

AMAT:

15.67

VRTX:

9.34

PB Ratio

AMAT:

18.96

VRTX:

4.31

Total Revenue (TTM)

AMAT:

$29.02B

VRTX:

$12.26B

Gross Profit (TTM)

AMAT:

$14.21B

VRTX:

$10.57B

EBITDA (TTM)

AMAT:

$9.92B

VRTX:

$5.19B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AMAT vs. VRTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AMAT
AMAT Risk / Return Rank: 9797
Overall Rank
AMAT Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
AMAT Sortino Ratio Rank: 9696
Sortino Ratio Rank
AMAT Omega Ratio Rank: 9696
Omega Ratio Rank
AMAT Calmar Ratio Rank: 9898
Calmar Ratio Rank
AMAT Martin Ratio Rank: 9898
Martin Ratio Rank

VRTX
VRTX Risk / Return Rank: 3737
Overall Rank
VRTX Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
VRTX Sortino Ratio Rank: 3434
Sortino Ratio Rank
VRTX Omega Ratio Rank: 3535
Omega Ratio Rank
VRTX Calmar Ratio Rank: 3838
Calmar Ratio Rank
VRTX Martin Ratio Rank: 3737
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AMAT vs. VRTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Applied Materials, Inc. (AMAT) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AMATVRTXDifference
Sharpe ratioReturn per unit of total volatility

+4.75

Sortino ratioReturn per unit of downside risk

+4.02

Omega ratioGain probability vs. loss probability

1.59

1.02

+0.58

Calmar ratioReturn relative to maximum drawdown

10.67

-0.14

+10.81

Martin ratioReturn relative to average drawdown

30.41

-0.29

+30.70

AMAT vs. VRTX - Sharpe Ratio Comparison

The current AMAT Sharpe Ratio is 4.65, which is higher than the VRTX Sharpe Ratio of -0.10. The chart below compares the historical Sharpe Ratios of AMAT and VRTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AMAT vs. VRTX - Drawdown Comparison

The maximum AMAT drawdown since its inception was -85.22%, smaller than the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for AMAT and VRTX.


Loading charts...

Drawdown Indicators


AMATVRTXDifference

Max Drawdown

Largest peak-to-trough decline

-85.22%

-91.77%

+6.55%

Max Drawdown (1Y)

Largest decline over 1 year

-21.37%

-23.56%

+2.19%

Max Drawdown (3Y)

Largest decline over 3 years

-49.88%

-29.07%

-20.81%

Max Drawdown (5Y)

Largest decline over 5 years

-55.14%

-29.07%

-26.07%

Max Drawdown (10Y)

Largest decline over 10 years

-55.14%

-41.60%

-13.54%

Current Drawdown

Current decline from peak

0.00%

-13.90%

+13.90%

Average Drawdown

Average peak-to-trough decline

-38.78%

-37.73%

-1.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.49%

11.30%

-3.81%

Volatility

AMAT vs. VRTX - Volatility Comparison

Applied Materials, Inc. (AMAT) has a higher volatility of 20.52% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 7.47%. This indicates that AMAT's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AMATVRTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.52%

7.47%

+13.05%

Volatility (6M)

Calculated over the trailing 6-month period

38.83%

20.71%

+18.12%

Volatility (1Y)

Calculated over the trailing 1-year period

49.03%

34.13%

+14.90%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

44.20%

28.53%

+15.67%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

42.94%

32.82%

+10.12%

Dividends

AMAT vs. VRTX - Dividend Comparison

AMAT's dividend yield for the trailing twelve months is around 0.34%, while VRTX has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AMAT
Applied Materials, Inc.
0.34%0.69%0.93%0.75%1.05%0.60%1.01%1.36%2.14%0.78%1.24%2.14%
VRTX
Vertex Pharmaceuticals Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

AMAT vs. VRTX - Financials Comparison

This section allows you to compare key financial metrics between Applied Materials, Inc. and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B3.00B4.00B5.00B6.00B7.00B8.00B20222023202420252026
7.91B
2.99B
(AMAT) Total Revenue
(VRTX) Total Revenue
Values in USD except per share items

AMAT vs. VRTX - Profitability Comparison

The chart below illustrates the profitability comparison between Applied Materials, Inc. and Vertex Pharmaceuticals Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%60.0%70.0%80.0%90.0%20222023202420252026
49.9%
86.9%
Portfolio components
AMAT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Applied Materials, Inc. reported a gross profit of 3.95B and revenue of 7.91B. Therefore, the gross margin over that period was 49.9%.

VRTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.59B and revenue of 2.99B. Therefore, the gross margin over that period was 86.9%.

AMAT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Applied Materials, Inc. reported an operating income of 2.52B and revenue of 7.91B, resulting in an operating margin of 31.9%.

VRTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vertex Pharmaceuticals Incorporated reported an operating income of 1.14B and revenue of 2.99B, resulting in an operating margin of 38.1%.

AMAT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Applied Materials, Inc. reported a net income of 2.81B and revenue of 7.91B, resulting in a net margin of 35.5%.

VRTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vertex Pharmaceuticals Incorporated reported a net income of 1.03B and revenue of 2.99B, resulting in a net margin of 34.5%.


Frequently Asked Questions


AMAT and VRTX have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AMAT has higher volatility (20.52%) compared to VRTX (7.47%). In terms of maximum drawdown, AMAT dropped -85.22% vs VRTX's -91.77%.

AMAT currently has the higher Sharpe Ratio (4.65 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AMAT and VRTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer